Research and Markets: Global CRO Market 2015-2019 with Covance, Parexel International, PRA Health Sciences & Quintiles Translational Dominating

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/znr5f3/global_cro_market) has announced the addition of the "Global CRO Market 2015-2019" report to their offering.

The analysts forecast the Global CRO market to grow at a CAGR of 9.83% over the period 2014-2019

Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills.

CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models.

Increased R&D by biopharmaceutical vendors is one of the major trends emerging in the market. Customers are increasingly opting for biopharmaceutical drugs rather than chemical pharmaceuticals drugs for the treatment of some diseases such as diabetes, cancer, and genetic diseases because biopharmaceutical drugs offer several advantages.

According to the report, increased outsourcing of R&D activities by global pharmaceutical and biopharmaceutical vendors is one of the main drivers of the market. Several tier I and tier II pharmaceutical and biopharmaceutical vendors are outsourcing R&D and clinical trial activities to CROs to reduce their expenditure on R&D activities.

Further, the report states that the shortage of experienced personnel to conduct various activities in CROs is one of the main challenges in the market. Moreover, many CROs do not have sufficient personnel to fulfill the R&D demands of several vendors

Key Vendors

  • Covance
  • Parexel International
  • PRA Health Sciences
  • Quintiles Translational

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Market Segmentation by Type of Service
  8. Market Segmentation by Therapeutic Area
  9. Geographical Segmentation
  10. Buying Criteria
  11. Market Growth Drivers
  12. Drivers and their Impact
  13. Market Challenges
  14. Impact of Drivers and Challenges
  15. Market Trends
  16. Trends and their Impact
  17. Vendor Landscape
  18. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/znr5f3/global_cro_market

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Manufacturing and Industry

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Manufacturing and Industry